Evaluation of novel epibatidine analogs in the rat nicotine drug discrimination assay and in the rat chronic constriction injury neuropathic pain model.
- DOI
- 10.3389/adar.2023.11622
- Published
- 2023
- Container
- Advances in drug and alcohol research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/adar.2023.11622,
title = {Evaluation of novel epibatidine analogs in the rat nicotine drug discrimination assay and in the rat chronic constriction injury neuropathic pain model.},
author = {Luque-Sanchez K and Felix J and Bilbrey J and Restrepo L and Reeves M and McMahon LR and Wilkerson JL},
year = {2023},
journal = {Advances in drug and alcohol research},
doi = {10.3389/adar.2023.11622},
url = {https://doi.org/10.3389/adar.2023.11622}
}RIS
TY - JOUR TI - Evaluation of novel epibatidine analogs in the rat nicotine drug discrimination assay and in the rat chronic constriction injury neuropathic pain model. AU - Luque-Sanchez K AU - Felix J AU - Bilbrey J AU - Restrepo L AU - Reeves M AU - McMahon LR AU - Wilkerson JL PY - 2023 JO - Advances in drug and alcohol research DO - 10.3389/adar.2023.11622 UR - https://doi.org/10.3389/adar.2023.11622 ER -
APA
K, L., J, F., J, B., L, R., M, R., LR, M., & JL, W. (2023). Evaluation of novel epibatidine analogs in the rat nicotine drug discrimination assay and in the rat chronic constriction injury neuropathic pain model.. Advances in drug and alcohol research. https://doi.org/10.3389/adar.2023.11622
Source records
- pubmed · retrieved 2026-09-27T09:39:25.641Z